Eliquis, Xarelto and Pradaxa are the most widely prescribed direct oral anticoagulants (DOACs) — blood thinners used to prevent strokes and dangerous clots in conditions like atrial fibrillation and DVT/PE. They differ in the details (apixaban and rivaroxaban block clotting factor Xa; dabigatran blocks thrombin), so the practical questions come down to how often you dose, whether food matters, how much kidney function changes the dose, and which emergency reversal agent applies. These are prescription-only; which one and what dose is decided by your prescriber based on your condition, kidney function and bleeding risk — do not start, stop, or switch on your own.
There is no single "best" DOAC — for many people they are broadly comparable at preventing clots and strokes, and the right pick comes down to practical fit your prescriber weighs. Apixaban (Eliquis) is twice daily, taken with or without food, and per its FDA label is the least affected by reduced kidney function (usable even in advanced kidney disease). Rivaroxaban (Xarelto) can be once daily for some indications, but its 15 mg and 20 mg doses must be taken with food, and the dose drops when kidney function is low. Dabigatran (Pradaxa) is twice daily, must be swallowed whole (never opened or crushed), leans most on the kidneys — but is the only one of the three reversed by its own targeted antibody, idarucizumab, while andexanet alfa reverses the other two. Prescription-only; which one and what dose is decided by your prescriber — do not start, stop, or switch on your own. This is general information, not medical advice.
| Eliquis apixaban | Xarelto rivaroxaban | Pradaxa dabigatran | |
|---|---|---|---|
| Active ingredient | Apixaban | Rivaroxaban | Dabigatran Etexilate Mesylate |
| Our rating | Not yet rated | 72/100 | 70/100 |
| Typical price | — | $0.98 /mL | ~$27.59 /30 |
| Dosing frequency | Twice daily | Once or twice daily — varies by condition | Twice daily |
| Reversal agent | Andexanet alfa (Andexxa) | Andexanet alfa (Andexxa) | Idarucizumab (Praxbind) |
| Renal-dose sensitive? | Least sensitive — usable even in advanced kidney disease; kidney function is one AFib dose-reduction factor (with age and weight) | Yes — lower dose when kidney function is reduced; avoided when it is very low | Most sensitive — leans heavily on the kidneys; dose reduced or not recommended when kidney function is low |
| Take with food? | No — with or without food | Yes — the 15 mg and 20 mg doses must be taken with food | With or without food — but swallow the capsule whole; never open, crush, or chew it |
| Good to know | Twice daily and the most forgiving on the kidneys — no food timing needed; reversed in emergencies by andexanet alfa. | Often once daily, but the 15 mg and 20 mg doses must be taken with food to absorb fully; also reversed by andexanet alfa. | Twice daily; swallow the capsule whole (opening it raises drug levels) and it depends most on kidney function — but has its own targeted reversal antibody, idarucizumab. |
Ratings are our independent FDA recall-safety score. General information, not medical advice.
Eliquis (apixaban)
Twice daily and the most forgiving on the kidneys — no food timing needed; reversed in emergencies by andexanet alfa.
Xarelto (rivaroxaban)
Often once daily, but the 15 mg and 20 mg doses must be taken with food to absorb fully; also reversed by andexanet alfa.
Pradaxa (dabigatran)
Twice daily; swallow the capsule whole (opening it raises drug levels) and it depends most on kidney function — but has its own targeted reversal antibody, idarucizumab.
These three prevent clots and strokes similarly for many patients, so the choice usually turns on practical factors your prescriber weighs — kidney function, dosing convenience and bleeding risk. Apixaban (Eliquis) is the most forgiving when kidney function is reduced and needs no food timing; rivaroxaban (Xarelto) offers once-daily convenience for some indications but its 15 mg and 20 mg doses must be taken with food; dabigatran (Pradaxa) must be swallowed whole and depends most on the kidneys, but has its own emergency reversal antibody (idarucizumab), while andexanet alfa reverses the other two. The single most important rule: never start, stop, or switch an anticoagulant on your own — every one of these carries an FDA boxed warning that stopping early raises the risk of a clot or stroke, so any change must go through your prescriber. Pharmaranks adds an independent FDA recall-safety score and a live NADAC cost-per-dose to each drug so you can compare safety history and price objectively, but which blood thinner and dose is right for you is an individualized medical decision. This is general information, not medical advice; ask your doctor or pharmacist.